98%
921
2 minutes
20
Smart wound dressings that integrate advanced drug delivery strategies and electrical stimulation (ES) represent a revolutionary approach for improving diabetic wound healing. However, limited drug loading efficiency and delayed reactivity to electrical inputs make it difficult to practically implement ES-controlled drug release in hydrogel-coated electrodes. In order to address these limitations, we developed a hydrogel-based electronic wound dressing patch that enables highly programmable, ES-triggered drug delivery. In particular, a hierarchically architectrual conductive polymer hydrogel composed of PEDOT: CHC/silk was designed to be used as an electroresponsive matrix and a drug reservoir. This hydrogel exhibited a high encapsulation efficiency (>90 %) for the hydrophobic drug ibuprofen and demonstrated exceptional mechanical resilience and electrochemical stability. Through systematic optimization of ES parameters such as voltage, frequency, and waveform, the system achieved precise spatiotemporal modulation of drug release. Notably, the integration of the hydrogel into interdigitated electrode arrays significantly enhanced delivery performance through improved field distribution and release control. In addition, the multifunctional patch also exhibited intrinsic antibacterial activity and biocompatibility, making it well-suited for clinical application. This work cumulatively introduces a wearable, electroceutical, and long-term active wound dressing system that is integratively assembled with wound protection, electrical treatment, and stimulus-sensitive drug delivery, hence being a promising approach to enhance diabetic wound healing through intelligent bioelectric treatment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jconrel.2025.113760 | DOI Listing |
Med Oncol
September 2025
Venom and Biotherapeutics Molecules Laboratory, Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Neuropeptide Y (NPY) and the voltage-gated potassium channel Kv1.3 are closely associated with breast cancer progression and apoptosis regulation, respectively. NPY receptors (NPYRs), which are overexpressed in breast tumors, contribute to tumor growth, migration, and angiogenesis.
View Article and Find Full Text PDFJ Neurooncol
September 2025
Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Purpose: Glioblastoma (GBM) remains one of the most aggressive primary brain tumors with poor survival outcomes and a lack of approved therapies. A promising novel approach for GBM is the application of photodynamic therapy (PDT), a localized, light-activated treatment using tumor-selective photosensitizers. This narrative review describes the mechanisms, delivery systems, photosensitizers, and available evidence regarding the potential of PDT as a novel therapeutic approach for GBM.
View Article and Find Full Text PDFCNS Drugs
September 2025
Global Health Neurology Lab, Sydney, NSW, 2150, Australia.
Acute ischemic stroke (AIS) remains a leading cause of mortality and long-term disability globally, with survivors at high risk of recurrent stroke, cardiovascular events, and post-stroke dementia. Statins, while widely used for their lipid-lowering effects, also possess pleiotropic properties, including anti-inflammatory, endothelial-stabilizing, and neuroprotective actions, which may offer added benefit in AIS management. This article synthesizes emerging evidence on statins' dual mechanisms of action and evaluates their role in reducing recurrence, improving survival, and mitigating cognitive decline.
View Article and Find Full Text PDFJ Clin Monit Comput
September 2025
Department of Anesthesiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Target-controlled infusion (TCI) systems, originally developed for intravenous drug administration of anesthetic drugs, enable precise drug delivery based on pharmacokinetic-pharmacodynamic (PKPD) models. While widely used in the operating room, their application in the intensive care unit (ICU) remains limited despite the complexity of drug dosing in critically ill patients. This scoping review evaluates existing evidence on the use of TCI systems in ICU settings, focusing on sedation, analgesia, and antibiotic administration.
View Article and Find Full Text PDFACS Appl Mater Interfaces
September 2025
Department of Chemistry, University of Wisconsin-Madison, 1101 University Ave., Madison, Wisconsin 53706, United States.
Slippery liquid-infused porous surfaces (or "SLIPS") can prevent bacterial surface fouling, but they do not inherently possess the means to kill bacteria or reduce cell loads in surrounding media. Past reports show that the infused liquids in these materials can be leveraged to load and release antimicrobial agents, but these approaches are generally limited to the use of hydrophobic agents that are soluble in the infused oily phases. Here, we report the design of so-called "proto-SLIPS" that address this limitation and permit the release of highly water-soluble (or oil-insoluble) agents.
View Article and Find Full Text PDF